International Journal of Gynecological Cancer

Spirituality in gynecological oncology: a review
pp. 183-201(19)
Authors: Ramondetta L.M.; Sills D.

The practicability of FIGO 2000 staging for gestational trophoblastic neoplasia
pp. 202-205(4)
Author: Ngan H.Y.S.

Tumor board in gynecologic oncology
pp. 206-209(4)
Authors: Santoso J.T.; Schwertner B.; Coleman R.L.; Hannigan E.V.

Multidisciplinary team working: is it both holistic and effective?
pp. 210-211(2)
Authors: Jefferies H.; Chan K.K.

Accuracy of frozen section in diagnosis of ovarian mass
pp. 212-219(8)
Authors: Tangjitgamol S.; Jesadapatrakul S.; Manusirivithaya S.; Sheanakul C.

Subjective versus objective nutritional assessment study in women with gynecological cancer: a prospective cohort trial
pp. 220-223(4)
Authors: Santoso J.T.; Cannada T.; O'Farrel B.; Alladi K.; Coleman R.L.

Long-term follow-up of a phase II trial of oral altretamine for consolidation of clinical complete remission in women with stage III epithelial ovarian cancer in the Southwest Oncology Group
pp. 224-228(5)
Authors: Alberts D.S.; Jiang C.; Liu P.Y.; Wilczynski S.; Markman M.; Rothenberg M.L.

Effect of laparoscopy versus laparotomy on circulating tumor cells using isolation by size of epithelial tumor cells
pp. 229-233(5)
Authors: lelievre L.; Paterlini-Brechot P.; Camatte S.; Tartour E.; Aggerbeck M.; Vilde F.; Lecuru F.

The anti-tumor immune responses induced by a fusion protein of ovarian carcinoma anti-idiotypic antibody 6B11ScFv and murine GM-CSF in BALB/c mice
pp. 234-241(8)
Authors: Cui H.; Chang X.-H.; Liu B.; Feng J.; Li Y.; Ye X.; Cao S.-J.; Fu T.-Y.; Yao Y.; Li H.-Q.; Qian H.-N.

Association between glutathione-S-transferase GSTP1 genotypes, GSTP1 over-expression, and outcome in epithelial ovarian cancer
pp. 242-250(9)
Authors: Howells R.E.J.; Dhar K.K.; Hoban P.R.; Jones P.W.; Fryer A.A.; Redman C.W.E.; Strange R.C.

Analyses of p53 expression pattern and BRCA mutations in patients with double primary breast and ovarian cancer
pp. 251-258(8)
Authors: Bruchim I.; Fishman A.; Friedman E.; Goldberg I.; Chetrit A.; Barshack I.; Dekel E.; Hirsh-Yechezkel G.; Modan B.; Kopolovic J.

A new prognostic model comprising p53, EGFR, and tumor grade in early stage epithelial ovarian carcinoma and avoiding the problem of inaccurate surgical staging
pp. 259-270(12)
Authors: Skírnisdóttir I.; Seidal T.; Sorbe B.

Sentinel lymph node biopsy in cervix and corpus uteri cancers
pp. 271-278(8)
Authors: Lelievre L.; Camatte S.; Le frere-belda M.A.; Kerrou K.; Froissart M.; Taurelle R.; vilde F.; lecuru F.

A comparison of prognoses of FIGO stage IB adenocarcinoma and squamous cell carcinoma
pp. 279-285(7)
Authors: Ayhan A.; Al R.A.; Baykal C.; Demirtas E.; Yüce K.

Prognostic factors in FIGO stage IB cervical cancer without lymph node metastasis and the role of adjuvant radiotherapy after radical hysterectomy
pp. 286-292(7)
Authors: Ayhan A.; Al R.A.; Baykal C.; Demirtas E.; Yüce K.

Are Muslim women less susceptible to oncogenic human papillomavirus infection? A study from rural eastern India
pp. 293-303(11)
Authors: Duttagupta C.; Sengupta S.; Roy M.; Sengupta D.; Bhattacharya P.; Laikangbam P.; Roy S.; Ghosh S.; Das R.

Early-stage vaginal carcinoma – an analysis of 70 patients
pp. 304-310(7)
Authors: Otton G.R.; Nicklin J.L.; Dickie G.J.; Niedetzky P.; Tripcony L.; Perrin L.C.; Crandon A.J.

Prediction of disease persistence after conization for microinvasive cervical carcinoma and cervical intraepithelial neoplasia grade 3
pp. 311-316(6)
Authors: Lin H.; Chang H.Y.; Huang C.C.; Changchien C.C.

Overall major histocompatibility complex class I expression is not downregulated in cervix cancer, as detected by immunoelectron microscopy
pp. 317-321(5)
Authors: Van Eijkeren M.A.; Roovers J.P.; Oorschot V.; Geuze H.J.

Anti-cancer effect of adenovirus p53 on human cervical cancer cell growth in vitro and in vivo
pp. 322-332(11)
Authors: Ahn W.S.; Bae S.M.; Lee J.M.; Namkoong S.E.; Yoo J.Y.; Seo Y.-S.; Nam S.L.; Cho Y.-L.; Nam K.H.; Kim C.K.; Kim Y.-W.

Matrix metalloproteinases-2, -3, and -9 secreted by explants of benign and malignant lesions of the uterine cervix
pp. 333-340(8)
Authors: Argüello-Ramírez J.; Pérez-Cárdenas E.; Delgado-Chávez R.; Solorza-Luna G.; Villa-Treviño S.; Arenas-Huertero F.

Feasibility of laparoscopic management of presumed stage I endometrial carcinoma and assessment of accuracy of myoinvasion estimates by frozen section: a gynecologic oncology group study
pp. 341-347(7)
Authors: Homesley H.D.; Boike G.; Spiegel G.W.

Risk of progression in complex and atypical endometrial hyperplasia: clinicopathologic analysis in cases with and without progestogen treatment
pp. 348-353(6)
Authors: Horn L.-C.; Schnurrbusch U.; Bilek K.; Hentschel B.; Einenkel J.

Expression of p27 and p53: comparative analysis of uterine carcinosarcoma and endometrial carcinoma
pp. 354-359(6)
Authors: Abargel A.; Avinoach I.; Kravtsov V.; Boaz M.; Glezerman M.; Menczer J.

EMA-EP regimen, as firstline multiple agent chemotherapy in high-risk GTT patients (stage II–IV)
pp. 360-365(6)
Authors: Ghaemmaghami F.; Modares M.; Arab M.; Behtash N.; Moosavi A.Z.; Khanafshar N.; Hanjani P.

The clinical presentation, treatment, and outcome of patients diagnosed with possible ectopic molar gestation
pp. 366-369(4)
Authors: Gillespie A.M.; Lidbury E.A.; Tidy J.A.; Hancock B.W.

A case of peripheral primitive neuroectodermal tumor of the ovary
pp. 370-372(3)
Authors: Kim K.-J.; Jang B.-W.; Lee S.-K.; Kim B.-K.; Nam S.-L.

Gastrointestinal stromal tumor arising in the rectovaginal septum
pp. 373-377(5)
Authors: Nasu K.; Ueda T.; Kai S.; Anai H.; Kimura Y.; Yokoyama S.; Miyakawa I.

Complete remission of ovarian endometrioid adenocarcinoma associated with hyperamylasemia and liver metastasis treated by paclitaxel and carboplatin chemotherapy: a case report
pp. 378-380(3)
Authors: Tohya T.; Shimajiri S.; Onoda C.; Yoshimura T.

Early-onset sigmoid colon perforation during concurrent chemoradiation in a patient with cervical cancer
pp. 381-383(3)
Authors: Lin H.; Chang C.-L.; Huang E.-Y.; Changchien C.-C.

Multiple, disseminated cutaneous metastases of vulvar squamous cell carcinoma
pp. 384-387(4)
Authors: Ghaemmaghami F.; Modares M.; Behtash N.; Moosavi A.Z.

Undifferentiated endometrial carcinoma of the uterus: marked effect of chemotherapy with tetrahydropyranyl-adriamycin, paclitaxel, and carboplatin
pp. 388-394(7)
Authors: Hayashi M.; Ueda Y.; Takimoto T.; Ohkura T.

Tamoxifen-related uterine malignancies: carcinomas or sarcomas?
pp. 395-395(1)

Letter to the Editor
pp. 396-396(1)

Response to the Letter of Vergote
pp. 397-397(1)

Nerve-sparing radical pelvic surgery
pp. 398-398(1)
Author: Mass C.P.